YD Bio Limited Ordinary Shares (YDES) Stock Ticker
Market factors today
Unlock the full YDES picture
About YD Bio Limited Ordinary Shares
Breeze Holdings Acquisition Corp. is a clinical-stage biopharmaceutical company based in Taipei, Taiwan. The firm concentrates its efforts on developing medical diagnostics for cancer prevention and creating exosome-based therapeutics, both of which aim to revolutionize treatment options for diseases with significant unmet medical needs.
YDES stock facts
| Ticker symbol | YDES |
| Exchange | NASDAQ Global Select |
| Sector | Healthcare |
| Industry | Biotechnology |
| Market cap | $405.9M |
| CEO | Ethan Shen |
| Employees | 15 |
| Headquarters | Taipei, TP, TW |
| IPO date | 2025-08-29 |
| Website | www.ydesgroup.com |
What you can see for YDES on Tickr
Live YDES price chart with overlays, the options chain, implied move, IV rank, options flow and Strategy Lab, financial statements and consensus estimates, analyst ratings, catalysts, news with AI scoring, and an AI chat that has read the YDES report.
Rankings
FAQ
What is the ticker symbol for YD Bio Limited Ordinary Shares?
The ticker symbol for YD Bio Limited Ordinary Shares is YDES, listed on the NASDAQ Global Select.
What is YDES?
Breeze Holdings Acquisition Corp. is a clinical-stage biopharmaceutical company based in Taipei, Taiwan. The firm concentrates its efforts on developing medical diagnostics for cancer prevention and creating exosome-based therapeutics, both of which aim to revolutionize treatment options for diseases with significant unmet medical needs.